Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 224

1.
4.

The use of adrenocorticotrophic hormone as a potential biomarker of pituitary pars intermedia dysfunction in horses.

Lee ZY, Zylstra R, Haritou SJ.

Vet J. 2010 Jul;185(1):58-61. doi: 10.1016/j.tvjl.2010.04.014.

PMID:
20537574
5.

Circannual variation in plasma adrenocorticotropic hormone concentrations in the UK in normal horses and ponies, and those with pituitary pars intermedia dysfunction.

Copas VE, Durham AE.

Equine Vet J. 2012 Jul;44(4):440-3. doi: 10.1111/j.2042-3306.2011.00444.x. Epub 2011 Aug 18.

PMID:
21848531
7.

Investigation of rhythms of secretion and repeatability of plasma adrenocorticotropic hormone concentrations in healthy horses and horses with pituitary pars intermedia dysfunction.

Rendle DI, Litchfield E, Heller J, Hughes KJ.

Equine Vet J. 2014 Jan;46(1):113-7. doi: 10.1111/evj.12114. Epub 2013 Aug 30.

PMID:
23742059
8.
9.

Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis.

Donaldson MT, Jorgensen AJ, Beech J.

J Am Vet Med Assoc. 2004 Apr 1;224(7):1123-7.

PMID:
15074858
10.

Evaluation of basal plasma α-melanocyte-stimulating hormone and adrenocorticotrophic hormone concentrations for the diagnosis of pituitary pars intermedia dysfunction from a population of aged horses.

Mc Gowan TW, Pinchbeck GP, Mc Gowan CM.

Equine Vet J. 2013 Jan;45(1):66-73. doi: 10.1111/j.2042-3306.2012.00575.x. Epub 2012 May 6.

PMID:
22563728
11.

Agreement in histologic assessments of the pituitary pars intermedia in aged horses.

McFarlane D, Miller LM, Craig LE, Dybdal NO, Habecker PL, Miller MA, Patterson JS, Cribb AE.

Am J Vet Res. 2005 Dec;66(12):2055-9.

PMID:
16379646
12.

Nitration and increased alpha-synuclein expression associated with dopaminergic neurodegeneration in equine pituitary pars intermedia dysfunction.

McFarlane D, Dybdal N, Donaldson MT, Miller L, Cribb AE.

J Neuroendocrinol. 2005 Feb;17(2):73-80.

PMID:
15796757
13.

Comparison of cortisol and ACTH responses after administration of thyrotropin releasing hormone in normal horses and those with pituitary pars intermedia dysfunction.

Beech J, Boston R, Lindborg S.

J Vet Intern Med. 2011 Nov-Dec;25(6):1431-8. doi: 10.1111/j.1939-1676.2011.00810.x. Epub 2011 Oct 7.

14.

Diagnostic testing for pituitary pars intermedia dysfunction in horses.

Dybdal NO, Hargreaves KM, Madigan JE, Gribble DH, Kennedy PC, Stabenfeldt GH.

J Am Vet Med Assoc. 1994 Feb 15;204(4):627-32.

PMID:
8163420
15.
16.

Cytokine dysregulation in aged horses and horses with pituitary pars intermedia dysfunction.

McFarlane D, Holbrook TC.

J Vet Intern Med. 2008 Mar-Apr;22(2):436-42. doi: 10.1111/j.1939-1676.2008.0076.x.

18.

Investigation of single and paired measurements of adrenocorticotropic hormone for the diagnosis of pituitary pars intermedia dysfunction in horses.

Rendle DI, Duz M, Beech J, Parkin T, Durham AE.

J Vet Intern Med. 2015 Jan;29(1):355-61. doi: 10.1111/jvim.12489. Epub 2014 Oct 13.

19.

Case series of equine pituitary pars intermedia dysfunction in a tropical climate.

Spelta CW, Axon JE.

Aust Vet J. 2012 Nov;90(11):451-6. doi: 10.1111/j.1751-0813.2012.00997.x. Epub 2012 Oct 11.

PMID:
23106327
20.

The effects of sample handling and N-phenylmaleimide on concentration of adrenocorticotrophic hormone in equine plasma.

Rendle DI, Litchfield E, Gough S, Cowling A, Hughes KJ.

Equine Vet J. 2015 Sep;47(5):587-91. doi: 10.1111/evj.12319. Epub 2014 Oct 7.

PMID:
24980684

Supplemental Content

Support Center